SLANH

Do novel biomarkers have utility in the diagnosis and prognosis of AKI?: CON  Manuscript Type: Debates in Nephrology. Leer Artículo Leer Artículo ... Seguir Leyendo

Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal replacement therapy for acute kidney injury. Seong Geun Kim, Jinwoo Lee, Donghwan Yun, Min Woo Kang, Yong Chul Kim, Dong Ki Kim, Kook‐Hwan Oh, Kwon Wook J ... Seguir Leyendo

Longitudinal trajectory of acidosis and mortality in acute kidney injury requiring continuous renal replacement therapy. Jinwoo Lee1, Seong Geun Kim1, Donghwan Yun1, Min Woo Kang1, Yong Chul Kim1, Dong Ki Kim1, Kook‐Hwan Oh1, Kwon Wook Jo ... Seguir Leyendo

Sepsis-associated acute kidney injury: consensus report ofthe 28th Acute Disease Quality Initiative workgroup Leer Artículo Leer Artículo ... Seguir Leyendo

Biomarkers for Early Diagnosis of AKI: Could It Backfire? Rolando Claure-Del Granado ,1,2 Etienne Macedo ,3 and Jonathan S. Chavez-In~iguez 4,5 Leer Artículo Leer Artículo ... Seguir Leyendo

Rationale for sequential extracorporeal therapy (SET) in sepsis Claudio Ronco1,2*, Lakhmir Chawla3, Faeq Husain‐Syed4,5 and John A. Kellum6,7 Leer Artículo Leer Artículo ... Seguir Leyendo

How to Determine Fluid Management Goals during Continuous Kidney Replacement Therapy in Patients with AKI: Focus on POCUS William Beaubien-Souligny ,1 Terren Trott,2 and Javier A. Neyra 3 Leer Artículo Leer Artículo ... Seguir Leyendo